| [1] |
Hilman D, Gat U. The evolutionary history of YAP and the Hippo/YAP pathway[J]. Mol Biol Evol, 2011, 28(8):2403-2417. doi: 10.1093/molbev/msr065
|
| [2] |
Halder G, Johnson RL. Hippo signaling: growth control and beyond[J]. Development, 2011, 138(1):9-22. doi: 10.1242/dev.045500
|
| [3] |
Varelas X. The Hippo pathway effectors TAZ and YAP in development, homeostasis and disease[J]. Development, 2014, 141(8):1614-1626. doi: 10.1242/dev.102376
|
| [4] |
Zhou Z, Hao Y, Liu N, et al. TAZ is a novel oncogene in non-small cell lung cancer[J]. Oncogene, 2011, 30(18):2181-2186. doi: 10.1038/onc.2010.606
|
| [5] |
Wang L, Shi S, Guo Z, et al. Overexpression of YAP and TAZ is an independent predictor of prognosis in colorectal cancer and related to the proliferation and metastasis of colon cancer cells[J]. PLoS One, 2013, 8(6):e65539. doi: 10.1371/journal.pone.0065539
|
| [6] |
Zhang J, Xu ZP, Yang YC, et al. Expression of Yes-associated protein in gastric adenocarcinoma and inhibitory effects of its knockdown on gastric cancer cell proliferation and metastasis[J]. Int J Immunopathol Pharmacol, 2012, 25(3):583-590. http://cn.bing.com/academic/profile?id=2104020201&encoded=0&v=paper_preview&mkt=zh-cn
|
| [7] |
Cordenonsi M, Zanconato F, Azzolin L, et al. The Hippo transducer TAZ confers cancer stem cell-related traits on breast cancer cells[J]. Cell, 2011, 147(4):759-772. doi: 10.1016/j.cell.2011.09.048
|
| [8] |
Kowalik MA, Saliba C, Pibiri M, et al. Yes-associated protein regulation of adaptive liver enlargement and hepatocellular carcinoma development in mice[J]. Hepatology, 2011, 53(6):2086-2096. doi: 10.1002/hep.24289
|
| [9] |
Lu L, Li Y, Kim SM, et al. Hippo signaling is a potent in vivo growth and tumor suppressor pathway in the mammalian liver[J]. Proc Natl Acad Sci U S A, 2010, 107(4):1437-1442. doi: 10.1073/pnas.0911427107
|
| [10] |
Zhao B, Wei X, Li W, et al. Inactivation of YAP oncoprotein by the Hippo pathway is involved in cell contact inhibition and tissue growth control[J]. Genes Dev, 2007, 21(21):2747-2761. doi: 10.1101/gad.1602907
|
| [11] |
Xu MZ, Yao TJ, Lee NP, et al. Yes-associated protein is an independent prognostic marker in hepatocellular carcinoma[J]. Cancer, 2009, 115(19):4576-4585. doi: 10.1002/cncr.v115:19
|
| [12] |
Fan M, Wang X, Xu G, et al. Bile acid signaling and liver regeneration[J]. Biochim Biophys Acta, 2014, DOI: 10.1016/j.bbagrm.2014.05.021[Epub ahead of print].
|
| [13] |
Yang F, Huang X, Yi T, et al. Spontaneous development of liver tumors in the absence of the bile acid receptor farnesoid X receptor[J]. Cancer Res, 2007, 67(3):863-867. doi: 10.1158/0008-5472.CAN-06-1078
|
| [14] |
Anakk S, Bhosale M, Schmidt VA, et al. Bile acids activate YAP to promote liver carcinogenesis[J]. Cell Rep, 2013, 5(4):1060-1069. doi: 10.1016/j.celrep.2013.10.030
|
| [15] |
Peng H, Dara L, Li TW, et al. MAT2B-GIT1 interplay activates MEK1/ERK 1 and 2 to induce growth in human liver and colon cancer[J]. Hepatology, 2013, 57(6):2299-2313. doi: 10.1002/hep.26258
|
| [16] |
Gailhouste L, Ezan F, Bessard A, et al. RNAi-mediated MEK1 knock-down prevents ERK1/2 activation and abolishes human hepatocarcinoma growth in vitro and in vivo[J]. Int J Cancer, 2010, 126(6):1367-1377. http://cn.bing.com/academic/profile?id=2001270137&encoded=0&v=paper_preview&mkt=zh-cn
|
| [17] |
Li L, Wang J, Zhang Y, et al. MEK1 promotes YAP and their interaction is critical for tumorigenesis in liver cancer[J]. FEBS Lett, 2013, 587(24):3921-3927. doi: 10.1016/j.febslet.2013.10.042
|
| [18] |
Lin XY, Zhang XP, Wu JH, et al. Expression of LATS1 contributes to good prognosis and can negatively regulate YAP oncoprotein in non-small-cell lung cancer[J]. Tumour Biol, 2014, 35(7):6435-6443. doi: 10.1007/s13277-014-1826-z
|
| [19] |
Liu JY, Li YH, Lin HX, et al. Overexpression of YAP 1 contributes to progressive features and poor prognosis of human urothelial carcinoma of the bladder[J]. BMC Cancer, 2013, 13:349. doi: 10.1186/1471-2407-13-349
|
| [20] |
Xia Y, Chang T, Wang Y, et al. YAP promotes ovarian cancer cell tumorigenesis and is indicative of a poor prognosis for ovarian cancer patients[J]. PLoS One, 2014, 9(3):e91770. doi: 10.1371/journal.pone.0091770
|
| [21] |
Wang L, Shi S, Guo Z, et al. Overexpression of YAP and TAZ is an independent predictor of prognosis in colorectal cancer and related to the proliferation and metastasis of colon cancer cells[J]. PLoS One, 2013, 8(6):e65539. doi: 10.1371/journal.pone.0065539
|
| [22] |
Sun PL, Kim JE, Yoo SB, et al. Cytoplasmic YAP expression is associated with prolonged survival in patients with lung adenocarcinomas and epidermal growth factor receptor tyrosine kinase inhibitor treatment[J]. Ann Surg Oncol, 2014[Epub ahead of print]. http://cn.bing.com/academic/profile?id=2037251489&encoded=0&v=paper_preview&mkt=zh-cn
|
| [23] |
Sheen-Chen SM, Huang CY, Tsai CH, et al. Yes-associated protein is not an independent prognostic marker in breast cancer[J]. Anticancer Res, 2012, 32(8):3321-3325. http://cn.bing.com/academic/profile?id=2145229804&encoded=0&v=paper_preview&mkt=zh-cn
|
| [24] |
Feng XH, Derynck R. Specificity and versatility in tgf-beta signaling through Smads[J]. Annu Rev Cell Dev Biol, 2005, 21:659-693. doi: 10.1146/annurev.cellbio.21.022404.142018
|
| [25] |
Attisano L, Wrana JL. Signal integration in TGF-β, WNT, and Hippo pathways[J]. F1000Prime Rep, 2013, 5:17. http://cn.bing.com/academic/profile?id=1995798600&encoded=0&v=paper_preview&mkt=zh-cn
|
| [26] |
Schlegelmilch K, Mohseni M, Kirak O, et al. Yap1 acts downstream of α-catenin to control epidermal proliferation[J]. Cell, 2011, 144(5):782-795. doi: 10.1016/j.cell.2011.02.031
|
| [27] |
Kim NG, Koh E, Chen X, et al. E-cadherin mediates contact inhibition of proliferation through Hippo signaling-pathway components[J]. Proc Natl Acad Sci U S A, 2011, 108(29):11930-11935. doi: 10.1073/pnas.1103345108
|
| [28] |
Fujii M, Toyoda T, Nakanishi H, et al. TGF-β synergizes with defects in the Hippo pathway to stimulate human malignant mesothelioma growth[J]. J Exp Med, 2012, 209(3):479-494. doi: 10.1084/jem.20111653
|
| [29] |
Hiemer SE, Szymaniak AD, Varelas X. The transcriptional regulators TAZ and YAP direct transforming growth factor β-induced tumorigenic phenotypes in breast cancer cells[J]. J Biol Chem, 2014, 289(19):13461-13474. doi: 10.1074/jbc.M113.529115
|
| [30] |
Kordestani R, Mirshafiee H, Hosseini SM, et al. Effect of hepatitis B virus X gene on the expression level of p53 gene using hep G2 cell line[J]. Avicenna J Med Biotechnol, 2014, 6(1):3-9. http://cn.bing.com/academic/profile?id=2171279885&encoded=0&v=paper_preview&mkt=zh-cn
|
| [31] |
Lu JW, Yang WY, Tsai SM, et al. Liver-specific expressions of HBx and src in the p53 mutant trigger hepatocarcinogenesis in zebrafish[J]. PLoS One, 2013, 8(10):e76951. doi: 10.1371/journal.pone.0076951
|
| [32] |
Shankar DB, Cheng JC, Kinjo K, et al. The role of CREB as a proto-oncogene in hematopoiesis and in acute myeloid leukemia[J]. Cancer Cell, 2005, 7(4):351-362. doi: 10.1016/j.ccr.2005.02.018
|
| [33] |
Zhang T, Zhang J, You X, et al. Hepatitis B virus X protein modulates oncogene Yes-associated protein by CREB to promote growth of hepatoma cells[J]. Hepatology, 2012, 56(6):2051-2059. doi: 10.1002/hep.25899
|
| [34] |
Bataller R, Brenner DA. Liver fibrosis[J]. J Clin Invest, 2005, 115(2):209-218. doi: 10.1172/JCI24282
|
| [35] |
Bai H, Zhang N, Xu Y, et al. Yes-associated protein regulates the hepatic response after bile duct ligation[J]. Hepatology, 2012, 56(3):1097-1107. doi: 10.1002/hep.25769
|
| [36] |
Hainaut P, Plymoth A. Targeting the hallmarks of cancer: towards a rational approach to next-generation cancer therapy[J]. Curr Opin Oncol, 2013, 25(1):50-51. doi: 10.1097/CCO.0b013e32835b651e
|
| [37] |
Francischetti I, Moreno JB, Scholz M, et al. Leukocytes and the inflammatory response in ischemia-reperfusion injury[J]. Rev Bras Cir Cardiovasc, 2010, 25(4):575-584. doi: 10.1590/S0102-76382010000400023
|
| [38] |
Orci LA, Lacotte S, Oldani G, et al. The role of hepatic ischemia-reperfusion injury and liver parenchymal quality on cancer recurrence[J]. Dig Dis Sci, 2014, 59(9):2058-2068. doi: 10.1007/s10620-014-3182-7
|
点击查看大图
下载:
